MAXITROL Side Effects

6755566-3 | Deafness
on May 25, 2010 Female patient from FRANCE , 88 years of age, was treated with Maxitrol (View Usage). Patient experienced the following unwanted or unexpected effects: deafness. Maxitrol dosage: Ophthalmic.

6750606-X | Ulcerative Keratitis, Visual Acuity Reduced, Visual Impairment
Patient was taking Maxitrol (View Usage). Patient had the following side effects: ulcerative keratitis, visual acuity reduced, visual impairment on May 13, 2010 from RUSSIAN FEDERATION Additional patient health information: Male patient , 45 years of age, was diagnosed with eye infection (What is eye infection?) and. Maxitrol dosage: 2 Gtt Qid Ou, Ophthalmic. Patient was hospitalized.

6713237-3 | Ulcerative Keratitis, Visual Acuity Reduced
Adverse event was reported on Apr 19, 2010 by a Female patient taking Maxitrol (View Usage) (Dosage: 2 Gtt Qid Ou Ophthalmic) was diagnosed with eye infection (What is eye infection?) and. Location: RUSSIAN FEDERATION , 45 years of age, After Maxitrol was administered, patient had the following side effects: ulcerative keratitis, visual acuity reduced. Patient was hospitalized.

6693678-3 | Ulcerative Keratitis, Visual Impairment
on Apr 06, 2010 Female patient from RUSSIAN FEDERATION , 45 years of age, was diagnosed with eye infection (What is eye infection?) and was treated with Maxitrol (View Usage). Patient experienced the following unwanted or unexpected effects: ulcerative keratitis, visual impairment. Maxitrol dosage: 2 Gtt Qid Ou, Ophthalmic. Patient was hospitalized.


6634168-3 | Blepharospasm, Dry Eye, Sensation Of Foreign Body
on Feb 24, 2010 Female patient from RUSSIAN FEDERATION , 68 years of age, was diagnosed with eye disorder and was treated with Maxitrol (View Usage). Patient had the following side effects: blepharospasm, dry eye, sensation of foreign body. Maxitrol dosage: . During the same period patient was treated with MAXIDEX (View Maxidex Review and Maxidex Label ), BETOPTIC (View Betoptic Review and Betoptic Label ). Patient was hospitalized.

6381242-5 | Accommodation Disorder, Headache, Intraocular Pressure Increased, Vision Blurred, Visual Impairment
Patient was taking Maxitrol (View Usage). After Maxitrol was administered, patient had the following side effects: accommodation disorder, headache (What is headache?), intraocular pressure increased, vision blurred, visual impairment on Sep 10, 2009 from GERMANY Additional patient health information: Male patient , child 9 years of age, was diagnosed with conjunctivitis and. Maxitrol dosage: Ou Qid.

6119768-1 | Corneal Disorder, Dry Eye, Impaired Work Ability, Lacrimation Increased, Ulcerative Keratitis
Adverse event was reported on Feb 23, 2009 by a Female patient taking Maxitrol (View Usage) (Dosage: 1 Gtt Qid) was diagnosed with postoperative care and. Location: NORWAY , 52 years of age, Patient experienced the following unwanted or unexpected effects: corneal disorder, dry eye, impaired work ability, lacrimation increased, ulcerative keratitis.

6015599-1 | Cataract, Eye Inflammation, Eye Pain, Glaucoma, Photophobia, Retinal Oedema, Visual Field Defect
on Dec 05, 2008 Female patient from GERMANY , 70 years of age, was treated with Maxitrol (View Usage). Patient had the following side effects: cataract (What is cataract?), eye inflammation, eye pain, glaucoma (What is glaucoma?), photophobia, retinal oedema, visual field defect. Maxitrol dosage: .

5940365-2 | Cataract, Chorioretinal Disorder, Eye Pain, Inflammation, Intraocular Pressure Increased, Photophobia
on Oct 17, 2008 Female patient from GERMANY , 70 years of age, was treated with Maxitrol (View Usage). After Maxitrol was administered, patient had the following side effects: cataract (What is cataract?), chorioretinal disorder, eye pain, inflammation, intraocular pressure increased, photophobia. Maxitrol dosage: .

5876079-7 | Corneal Deposits, Corneal Erosion, Intraocular Pressure Increased, No Therapeutic Response
Patient was taking Maxitrol (View Usage). Patient experienced the following unwanted or unexpected effects: corneal deposits, corneal erosion, intraocular pressure increased, no therapeutic response on Aug 25, 2008 from GERMANY Additional patient health information: Male patient , 56 years of age, . Maxitrol dosage: 5 Times Daily Opthalmic. During the same period patient was treated with KANAMYCIN SULFATE (Opthalmic) (View Kanamycin Sulfate Review and Kanamycin Sulfate Label ), TOBRADEX (Opthalmic) (View Tobradex Review and Tobradex Label ), COSOPT (COSOPT) (View Cosopt (cosopt) Review and Cosopt (cosopt) Label ), BOTOX (BOTULINUM TOXIN TYPE A) (View Botox (botulinum Toxin Type A) Review and Botox (botulinum Toxin Type A) Label ), ACTIHAEMYL (BLOOD, CALF, DEPROT., LMW PORTION) (View Actihaemyl (blood, Calf, Deprot., Lmw Portion) Review and Actihaemyl (blood, Calf, Deprot., Lmw Portion) Label ).

5876078-5 | Cataract, Eye Inflammation, Eye Pain, Intraocular Pressure Increased, Reading Disorder
Adverse event was reported on Aug 26, 2008 by a Female patient taking Maxitrol (View Usage) (Dosage: Ophthalmic) . Location: GERMANY , 70 years of age, Patient had the following side effects: cataract (What is cataract?), eye inflammation, eye pain, intraocular pressure increased, reading disorder.

5859139-6 | Dacryocystitis, Eye Swelling, Eyelid Oedema, Lacrimation Increased, Mydriasis
on Aug 08, 2008 Male patient from FRANCE , child 6 years of age, was diagnosed with conjunctivitis and was treated with Maxitrol (View Usage). After Maxitrol was administered, patient had the following side effects: dacryocystitis, eye swelling, eyelid oedema, lacrimation increased, mydriasis. Maxitrol dosage: Ophthalmic. During the same period patient was treated with ATROPINE SULFATE (Ophthalmic) (View Atropine Sulfate Review and Atropine Sulfate Label ), RIFAMYCINE (RIFAMYCIN SODIUM) (View Rifamycine (rifamycin Sodium) Review and Rifamycine (rifamycin Sodium) Label ), DACUDOSES (NATUSAN) (View Dacudoses (natusan) Review and Dacudoses (natusan) Label ). Patient was hospitalized.

5857232-5 | Cataract, Eye Inflammation, Eye Pain, Intraocular Pressure Increased
on Aug 07, 2008 Female patient from GERMANY , 70 years of age, was treated with Maxitrol (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), eye inflammation, eye pain, intraocular pressure increased. Maxitrol dosage: Ophthalmic.

5809766-7 | International Normalised Ratio Increased
Patient was taking Maxitrol (View Usage). Patient had the following side effects: international normalised ratio increased on Jun 25, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 76 years of age, was diagnosed with cataract operation and. Maxitrol dosage: Qid Ophthalmic. During the same period patient was treated with WAFARIN (WARFARIN) (View Wafarin (warfarin) Review and Wafarin (warfarin) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CO DYDRAMOL (PARAMOL 118) (View Co-dydramol (paramol-118) Review and Co-dydramol (paramol-118) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5798695-3 | Corneal Deposits, Corneal Erosion, Intraocular Pressure Increased, Organ Transplant
Adverse event was reported on Jun 16, 2008 by a Male patient taking Maxitrol (View Usage) (Dosage: 5 Times Daily Ophthalmic) . Location: GERMANY , 56 years of age, After Maxitrol was administered, patient had the following side effects: corneal deposits, corneal erosion, intraocular pressure increased, organ transplant (What is organ transplant?). During the same period patient was treated with KANAMYCIN SULFATE (Ophthalmic) (View Kanamycin Sulfate Review and Kanamycin Sulfate Label ), TOBRADEX (Ophthalmic) (View Tobradex Review and Tobradex Label ), COSOPT (COSOPT) (View Cosopt (cosopt) Review and Cosopt (cosopt) Label ), BOTOX (BOTULINUM TOXIN TYPE A) (View Botox (botulinum Toxin Type A) Review and Botox (botulinum Toxin Type A) Label ), ACTIHAEMYL (BLOOD, CALF, DEPROT., 1MW PORTION) (View Actihaemyl (blood, Calf, Deprot., 1mw Portion) Review and Actihaemyl (blood, Calf, Deprot., 1mw Portion) Label ), ACLO (ACECLOFENAC) (View Aclo (aceclofenac) Review and Aclo (aceclofenac) Label ).

5797903-2 | Dacryocystitis, Eye Swelling, Eyelid Oedema, Fistula, Lacrimation Increased, Mydriasis
on Jun 16, 2008 Male patient from FRANCE , child 6 years of age, was treated with Maxitrol (View Usage). Patient experienced the following unwanted or unexpected effects: dacryocystitis, eye swelling, eyelid oedema, fistula (What is fistula?), lacrimation increased, mydriasis. Maxitrol dosage: Ophthalmic. During the same period patient was treated with ATROPINE SULFATE (Ophthalmic) (View Atropine Sulfate Review and Atropine Sulfate Label ), RIFAMYCINE (RIFAMYCIN SODIUM) (View Rifamycine (rifamycin Sodium) Review and Rifamycine (rifamycin Sodium) Label ), DACUDOSES (NATUSAN) (View Dacudoses (natusan) Review and Dacudoses (natusan) Label ). Patient was hospitalized.

5775472-0 | Chills, Cytolytic Hepatitis, Eosinophilia, Lung Disorder, Pain, Pyrexia, Rash
on Jun 02, 2008 Female patient from FRANCE , 51 years of age, was treated with Maxitrol (View Usage). Patient had the following side effects: chills, cytolytic hepatitis, eosinophilia, lung disorder, pain (What is pain?), pyrexia, rash (What is rash?). Maxitrol dosage: . Patient was hospitalized.

5368279-X | Muscle Haemorrhage
Patient was taking Maxitrol (View Usage). After Maxitrol was administered, patient had the following side effects: muscle haemorrhage on Jun 06, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 80 years of age, . Maxitrol dosage: Ophtalmic, Eye Drops Suspension. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CALCICHEW D3 (LEKOVIT CA) (View Calcichew D3 (lekovit Ca) Review and Calcichew D3 (lekovit Ca) Label ), CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL) (View Candesartan Cilexetil (candesartan Cilexetil) Review and Candesartan Cilexetil (candesartan Cilexetil) Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

5343415-X | Corneal Abscess, Corneal Leukoma, Corneal Oedema, Hypopyon, Pseudomonas Infection, Visual Acuity Reduced
Adverse event was reported on Apr 19, 2007 by a Female patient taking Maxitrol (View Usage) (Dosage: Eye Ointment, Bid, Ophthalmic) was diagnosed with conjunctivitis, corneal abrasion and. Location: BELGIUM , 30 years of age, Patient experienced the following unwanted or unexpected effects: corneal abscess, corneal leukoma, corneal oedema, hypopyon, pseudomonas infection, visual acuity reduced. Patient was hospitalized.

5262655-1 | White Blood Cell Count Decreased
on Feb 20, 2007 Male patient from UNITED KINGDOM , 81 years of age, was treated with Maxitrol (View Usage). Patient had the following side effects: white blood cell count decreased. Maxitrol dosage: Eye Drops 3/ 1days Ophthalmic. During the same period patient was treated with MYDRILATE(CYCLOPENTOLATE HYHDROCHLORIDE) (View Mydrilate(cyclopentolate Hyhdrochloride) Review and Mydrilate(cyclopentolate Hyhdrochloride) Label ), EZETIMIBE(EZETIMIBE) (View Ezetimibe(ezetimibe) Review and Ezetimibe(ezetimibe) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), QUININE(QUINIDINE SULFATE) (View Quinine(quinidine Sulfate) Review and Quinine(quinidine Sulfate) Label ).

5248643-X | Anaphylactic Reaction, Eye Swelling, Ocular Discomfort, Ocular Hyperaemia
on Feb 26, 2007 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with superficial injury of eye and was treated with Maxitrol (View Usage). After Maxitrol was administered, patient had the following side effects: anaphylactic reaction, eye swelling, ocular discomfort, ocular hyperaemia. Maxitrol dosage: 1 Drop Ophthalmic. Patient was hospitalized.

5054036-0 | Corneal Abrasion, Corneal Thinning, Ulcerative Keratitis
Patient was taking Maxitrol (View Usage). Patient experienced the following unwanted or unexpected effects: corneal abrasion, corneal thinning, ulcerative keratitis on Jan 29, 2006 from NORWAY Additional patient health information: Female patient , 77 years of age, . Maxitrol dosage: Opht. During the same period patient was treated with FUSIDIC ACID 1% EYE DROPS (View Fusidic Acid 1% Eye Drops Review and Fusidic Acid 1% Eye Drops Label ), CARBOMER (View Carbomer Review and Carbomer Label ).